Gemtuzumab Ozogamicin With or Without Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia

PHASE2CompletedINTERVENTIONAL
Enrollment

106

Participants

Timeline

Start Date

June 30, 2000

Primary Completion Date

January 31, 2002

Conditions
Leukemia
Interventions
DRUG

cytarabine

DRUG

etoposide

DRUG

gemtuzumab ozogamicin

DRUG

idarubicin

DRUG

mitoxantrone hydrochloride

Trial Locations (18)

8000

A.Z. St. Jan, Bruges

39100

Ospedale Generale Regionale, Bolzano

41000

University Hospital Rebro, Zagreb

69437

Hopital Edouard Herriot, Lyon

75181

Hotel Dieu de Paris, Paris

75743

Hopital Necker, Paris

89100

Ospedali Riuniti, Reggio Calabria

A-6020

Innsbruck Universitaetsklinik, Innsbruck

B-2650

Universitair Ziekenhuis Antwerpen, Edegem

B-4000

CHU Sart-Tilman, Liège

D-69115

Medizinische Klinik und Poliklinik, Heidelberg

D-72076

Eberhard Karls Universitaet, Tübingen

00144

Ospedale San Eugenio, Rome

00161

Azienda Policlinico Umberto Primo, Rome

00168

Policlinico A. Gemelli - Universita Cattolica del Sacro Cuore, Rome

5211 NL

Groot Ziekengasthuis 's-Hertogenbosch, 's-Hertogenbosch

2300 CA

Leiden University Medical Center, Leiden

NL-6500 HB

University Medical Center Nijmegen, Nijmegen

All Listed Sponsors
lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK

NCT00006122 - Gemtuzumab Ozogamicin With or Without Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia | Biotech Hunter | Biotech Hunter